These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2570833)

  • 1. Pharmacokinetic profile of idazoxan in the beagle dog.
    Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
    J Pharm Pharmacol; 1989 Jun; 41(6):384-7. PubMed ID: 2570833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
    Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
    Drug Metab Dispos; 1989; 17(6):673-6. PubMed ID: 2575506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic-pharmacodynamic linking model for the alpha 2-adrenergic antagonism of idazoxan on clonidine-induced mydriasis in the rat.
    Valles J; Obach R; Menargues A; Pruñonosa J; Jane F
    J Pharm Pharmacol; 1995 Feb; 47(2):157-61. PubMed ID: 7602472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and metabolism of idazoxan in the rat.
    Lewis CJ; Havler ME; Humphrey MJ; Lloyd-Jones JG; McCleavy MA; Muir NC; Waltham K
    Xenobiotica; 1988 May; 18(5):519-32. PubMed ID: 2899932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics after intravenous and oral administration in man of the alpha 2-adrenoreceptor antagonist idazoxan (RX781094).
    Muir NC; Lloyd-Jones JG; Nichols JD; Clifford JM
    Eur J Clin Pharmacol; 1986; 29(6):743-5. PubMed ID: 2872058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in man.
    Muir NC; Doxey JC; Havler ME; Clifford JM
    J Pharmacol Methods; 1987 Sep; 18(2):95-102. PubMed ID: 2887703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idazoxan: a novel pharmacological tool for the study of alpha 2-adrenoceptors.
    Dabiré H
    J Pharmacol; 1986; 17(2):113-8. PubMed ID: 2875218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cyanamide in dog and rat.
    Obach R; Colom H; Arso J; Peraire C; Pruñonosa J
    J Pharm Pharmacol; 1989 Sep; 41(9):624-7. PubMed ID: 2573707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.
    Brown MJ; Harland D
    Br J Pharmacol; 1984 Nov; 83(3):657-65. PubMed ID: 6150737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
    Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
    Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postischemic administration of idazoxan, an alpha-2 adrenergic receptor antagonist, decreases neuronal damage in the rat brain.
    Gustafson I; Miyauchi Y; Wieloch TW
    J Cereb Blood Flow Metab; 1989 Apr; 9(2):171-4. PubMed ID: 2564004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of idazoxan on forskolin-stimulated adenylate cyclase activity through 5-hydroxytryptamine1A receptors.
    Kawai N; Yamamoto T; Baba A; Yamamoto H; Moroji T
    Arzneimittelforschung; 1994 Jan; 44(1):1-3. PubMed ID: 7907870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]idazoxan binding at non-alpha 2-adrenoceptors in rabbit adipocyte membranes.
    Langin D; Lafontan M
    Eur J Pharmacol; 1989 Jan; 159(2):199-203. PubMed ID: 2565242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality.
    Sun J; Zhang L; Song J; Tian S; Huang C; Feng Z; Lv Y; Du G
    J Ethnopharmacol; 2013 Jul; 148(2):617-23. PubMed ID: 23707334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
    Dalton JT; Meyer MC; Golub AL
    Drug Metab Dispos; 1999 Apr; 27(4):432-5. PubMed ID: 10232930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RX781094 a potent and selective alpha 2-adrenergic antagonist. Effects in adipocytes and hepatocytes.
    Pushpendran CK; García-Sáinz JA
    Eur J Pharmacol; 1984 Apr; 99(4):337-9. PubMed ID: 6145604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of xylazine induced sedation by idazoxan in calves.
    Doherty TJ; Ballinger JA; McDonell WN; Pascoe PJ; Valliant AE
    Can J Vet Res; 1987 Apr; 51(2):244-8. PubMed ID: 2886207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.